Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancer

Lung Cancer

Volumn 64, Issue 3, 2009, Pages 271-276

  Malentacchi, Francesca ^a   Simi, Lisa ^a   Nannelli, Caterina ^a   Andreani, Matteo ^b   Janni, Alberto ^b   Pastorekova, Silvia ^c   Orlando, Claudio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c INSTITUTE OF VIROLOGY   (Slovakia)

Author keywords

Alternative splicing; Cancer progression; Hypoxia; Pericellular pH regulation; Prognosis; Real time RT PCR

Indexed keywords

CARBONATE DEHYDRATASE IX; MESSENGER RNA;

ADULT; AGED; ALTERNATIVE RNA SPLICING; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HAZARD RATIO; HUMAN; HUMAN TISSUE; HYPOXIA; LUNG NON SMALL CELL CANCER; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; ALTERNATIVE SPLICING; ANTIGENS, NEOPLASM; CARBONIC ANHYDRASES; CARCINOMA, NON-SMALL-CELL LUNG; CELL HYPOXIA; CELL PROLIFERATION; DISEASE PROGRESSION; EXONS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROTEIN ISOFORMS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 67349229817     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.10.001     Document Type: Article

References (38)

1. Brizel D.M., Scully S.P., Harrelson J.M., Layfield L.J., Dodge R.K., Charles H.C., et al. Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas. Cancer Res 56 (1996) 5347-5350
2. Graeber T.G., Osmanian C., Jacks T., Housman D.E., Koch C.J., Lowe S.W., et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379 (1996) 88-91
3. Höckel M., Schlenger K., Mitze M., Schäffer U., and Vaupel P. Hypoxia and radiation response in human tumors. Semin Radiat Oncol 6 (1996) 3-9
4. Reynolds T.Y., Rockwell S., and Glazer P.M. Genetic instability induced by the tumor microenvironment. Cancer Res 56 (1996) 5754-5757
5. Kim C.Y., Tsai M.H., Osmanian C., Graeber T.G., Lee J.E., Giffard R.G., et al. Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions. Cancer Res 57 (1997) 4200-4204
6. Sly W.S., and Hu P.Y. Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu Rev Biochem 64 (1995) 375-401
7. Wykoff C.C., Beasley N.J.P., Watson P.H., Turner K.J., Pastorek J., Sibtain A., et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 60 (2000) e7075-e7083
8. Beasley N.J., Wykoff C.C., Watson P.H., Leek R., Turley H., Gatter K., et al. Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. Cancer Res 61 (2001) 5262-5267
9. Watson P.H., Chia S.K., Wykoff C.C., Han C., Leek R.D., Sly W.S., et al. Carbonic anhydrase XII is a marker of good prognosis in invasive breastcarcinoma. Br J Cancer 88 (2003) 1065-1070
10. Giatromanolaki A., Koukourakis M.I., Sivridis E., Pastorek J., Wykoff C.C., Gatter K.C., et al. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res 61 (2001) 7992-7998
11. Stubbs M., McSheehy P.M., Griffiths J.R., and Bashford C.L. Causes and consequences of tumour acidity and implications for treatment. Mol Med Today 6 (2000) 15-19
12. Thiry A., Dogne J.M., Masereel B., and Supuran C.T. Targeting tumor-associated carbonic anhydrase IX in cancer therapy. Trends Pharmacol Sci 27 (2006) 566-573
13. Potter C.P., and Harris A.L. Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer. Br J Cancer 89 (2003) 2-7
14. Pastorek J., Pastorekova S., Callebaut I., Mornon J.P., Zelnik V., Opavsky R., et al. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene 9 (1994) 2877-2888
15. Gray Lh., Conger Ad., Ebert M., Hornsey S., and Scott Oc. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 26 (1953) 638-648
16. Chia S., Ragaz J., Makretsov N., Cheang M., Hayes M., Gilks B., et al. Carbonic anhydrase IX (CA IX) as a predictive marker for benefit from post-mastectomy adjuvant locoregional radiation (RT): results from the British Columbia (BC) randomized radiation trial. J Clin Oncol 23 (2005) 16S
17. Chia S.K., Wykoff C.C., Watson P.H., Han C., Leek R.D., Pastorek J., et al. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol 19 (2001) 3660-3668
18. Loncaster J.A., Harris A.L., Davidson S.E., Logue J.P., Hunter R.D., Wycoff C.C., et al. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res 61 (2001) 6394-6399
19. Kaanders J.H., Wijffels K.I., Marres H.A., Ljungkvist A.S., Pop L.A., van den Hoogen F.J., et al. Pimonidazole binding and tumour vascularity predict for treatment outcome in head and neck cancer. Cancer Res 62 (2002) 7066-7074
20. Swinson D.E., Jones J.L., Richardson D., Wykoff C., Turley H., Pastorek J., et al. Carbonic anhydrase IX expression, a novel surrogate marker of tumour hypoxia, is associated with a poor prognosis in non-small-cell lung cancer. J Clin Oncol 21 (2003) 473-482
21. Hussain S.A., Palmer D.H., Ganesan R., Hiller L., Gregory J., Pastorek J., et al. Role of hypoxic marker CA IX in transitional cell carcinoma of the bladder. Oncol Rep 11 (2004) 1005-1010
22. McKierman J.M., Buttyan R., Bander N.H., Stifelman M.D., Katz A.E., Chen M.W., et al. Expression of the tumour-associated gene MN: a potential biomarker for human renal cell carcinoma. Cancer Res 57 (1997) 2362-2365
23. Vermylen P., Roufosse C., Burny A., Verhest A., Bosschaerts T., Pastorekova S., et al. Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma. Eur Respir J 14 (1999) 806-811
24. Kim S.J., Rabbani Z.N., Dewhirst M.W., Vujaskovic Z., Vollmer R.T., Schreiber E.G., et al. Expression of HIF-1α, CAIX, VEGF and MMP-9 in surgically resected non-small cell lung cancer. Lung Cancer 49 (2005) 325-335
25. Kim S.J., Rabbani Z., Vollmer R.T., Schreiber E.G., Oosterwijk E., Dewhirst M.K., et al. Carbonic anhydrase IX in early stage non small cell lung cancer. Clin Cancer Res 10 (2004) 7925-7933
26. Le Q.T., Chen E., Salim A., Cao H., Kong C.S., Whyte R., et al. An evaluation of tumor oxygenation and gene expression in patients with early state non-small cell lung cancers. Clin Cancer Res 12 5 (2006) 1507-1514
27. Kon-no H., Ishii G., Nagai K., Yoshida J., Nishimura M., Nara M., et al. Carbonic anhydrase IX expression is associated with tumor progression and a poor prognosis of lung adenocarcinoma. Lung Cancer 54 (2006) 409-418
28. Simi L., Venturini G., Malentacchi F., Gelmini S., Andreani M., Janni A., et al. Quantitative analysis of carbonic anhydrase IX mRNA in human non-small cell lung cancer. Lung Cancer 52 (2006) 59-66
29. Barathova M., Takacova M., Holotnakova T., Gibadulinova A., Ohradanova A., Zatovicova M., et al. Alternative splicing variant of the hypoxia marker carbonic anhydrase IX expressed independently of hypoxia and tumour phenotype. Br J Cancer 98 (2008) 129-136
30. Travis W.D., and Colby T.V. International histological classification of tumor. 3rd ed. (1999), Springer/World Health Organization, Geneva, Switzerland
31. Hockel M., and Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93 (2001) 266-276
32. Brizel D.M., Sibley G.S., Prosnitz L.R., Scher R.L., and Dewhirst M.W. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 38 (1997) 285-289
33. Smith E., Stratford I.J., and Adams G.E. Cytotoxicity of adriamycin on aerobic and hypoxic Chinese hamster V79 cells in vitro. Br J Cancer 42 (1980) 568-573
34. Harris A.L. Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2 (2002) 38-47
35. Airley R.E., Loncaster J., Raleigh J.A., Harris A.L., Davidson S.E., Hunter R.D., et al. GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding. Int J Cancer 104 (2003) 85-91
36. De Schutter H., Landuyt W., Verbeken E., Goethals L., Hermans R., and Nuyts S. The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy. BMC Cancer 5 (2005) 42
37. Koukourakis M.I., Bentzen S.M., Giatromanolaki A., Wilson G.D., Daley F.M., Saunders M.I., et al. Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. J Clin Oncol 24 (2006) 727-735
38. Swinson D.E., Cox G., and O'Byrne K.J. Coexpression of epidermal growth factor receptor with related factors is associated with a poor prognosis in non-small-cell lung cancer. Br J Cancer 91 (2004) 1301-1307